| publication name | Role of CD44 and Her2/neu in predicting the behavior of transitional cell carcinoma of the urinary bladder |
|---|---|
| Authors | Ghada A. Abd El-Fattah (MD), and Rasha M. El-Sawi (MD), Rasha M. Abd-Rabuh (MD), |
| year | 2018 |
| keywords | |
| journal | |
| volume | Not Available |
| issue | Not Available |
| pages | Not Available |
| publisher | Not Available |
| Local/International | Local |
| Paper Link | Not Available |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
Urinary bladder cancer ranks the ninth in the worldwide cancer incidence (Ploeg, et al, 2009). According to WHO, transitional cell carcinoma (TCC) accounts for 90% of all bladder tumors (Koyuncuer, 2013). In Egypt, according to NCI registry, urinary bladder carcinoma constituted 12.22% of total malignant tumors. There was a significant rise in the incidence of TCC in Egypt in the last years. In the cancer registry during the years 1985- 1989, TCC represented 30.89% of all bladder cancers. This incidence raised to 64.20% during the years 2003-2004